Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,429,078
+$7,995,707 QoQ
Shares Held
842,089
+5.0% QoQ
Ownership
0.811%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NRIX ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,429,078 | 842,089 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,433,371 | 802,153 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $13,972,503 | 736,558 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,444,938 | 481,054 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,726,932 | 327,211 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,932,408 | 415,186 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,843,614 | 150,935 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,103,645 | 138,124 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,619,094 | 221,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,428,486 | 97,176 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $195,419 | 18,936 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,295,096 | 546,450 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,874,367 | 588,025 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,605,090 | 631,204 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,922,497 | 721,539 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,698,342 | 130,341 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,112,602 | 87,814 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $736,224 | 52,550 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,562,507 | 88,515 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,249,154 | 75,072 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $740,425 | 27,909 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $973,240 | 31,304 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $238,609 | 7,257 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $297,397 | 8,519 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||